Loading data for SER — first visit, this takes a few seconds.
Serina Therapeutics Inc. (SER)
NYSE American: SER
· Real-Time Price · USD
2.65
-0.07 (-2.57%)
At close: Aug 20, 2026, 8:00 PM
2.58
-2.64%
After-hours: 6:00 PM
The price, the headline numbers and the latest news, in one place.
Serina Therapeutics Inc. (SER) Stock Price, Analysis & Data
-2.57% (1D)
No data available
| Bid | 2.5 |
| Market Cap | 67.31M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -23.93M |
| n/a | |
| -1.87 | |
| n/a | |
| -2.52 | |
| P/B (ttm) | 3.11 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 2.86 |
| Volume | 24,758 |
| Avg. Volume (20D) | 85,467 |
| Open | 2.64 |
| Previous Close | 2.72 |
| Day's Range | 2.56 - 2.69 |
| 52-Week Range | 1.22 - 7.92 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SER
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early ...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 29, 2018
Employees 16
Stock Exchange NYSE American
Ticker Symbol SER
Website https://serinatherapeutics.com
Financial Performance
In 2025, Serina Therapeutics's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -19.18M, an increase of 72.17%.
Financial StatementsEarnings Surprise
Serina Therapeutics has released their quarterly earnings on Aug 13, 2026:
